Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124875072 | 12487507 | 2 | F | 20160628 | 20160622 | 20160712 | EXP | US-AUROBINDO-AUR-APL-2016-08073 | AUROBINDO | 56.00 | YR | F | Y | 0.00000 | 20160712 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124875072 | 12487507 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNK | Y | U | 78021 | ||||||||
| 124875072 | 12487507 | 2 | I | RITONAVIR. | RITONAVIR | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 124875072 | 12487507 | 3 | C | ABACAVIR W/LAMIVUDINE | ABACAVIRLAMIVUDINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124875072 | 12487507 | 4 | C | ATAZANAVIR | ATAZANAVIR | 1 | Unknown | UNK | U | 0 | |||||||||
| 124875072 | 12487507 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | UNK | U | 0 | |||||||||
| 124875072 | 12487507 | 6 | C | TENOFOVIR | TENOFOVIR | 1 | Unknown | UNK | Y | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124875072 | 12487507 | 1 | Hypertension |
| 124875072 | 12487507 | 2 | HIV infection |
| 124875072 | 12487507 | 3 | HIV infection |
| 124875072 | 12487507 | 4 | HIV infection |
| 124875072 | 12487507 | 5 | Hypertension |
| 124875072 | 12487507 | 6 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124875072 | 12487507 | HO |
| 124875072 | 12487507 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124875072 | 12487507 | Acute kidney injury | |
| 124875072 | 12487507 | Asthenia | |
| 124875072 | 12487507 | Atrioventricular block complete | |
| 124875072 | 12487507 | Atrioventricular block first degree | |
| 124875072 | 12487507 | Blood bicarbonate decreased | |
| 124875072 | 12487507 | Blood creatinine increased | |
| 124875072 | 12487507 | Blood potassium increased | |
| 124875072 | 12487507 | Bradycardia | |
| 124875072 | 12487507 | Conduction disorder | |
| 124875072 | 12487507 | Dizziness | |
| 124875072 | 12487507 | Drug interaction | |
| 124875072 | 12487507 | Oedema | |
| 124875072 | 12487507 | Orthostatic hypotension | |
| 124875072 | 12487507 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |